These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24188993)

  • 1. Variable impact of intracavitary brachytherapy fractionation schedule on biologically effective dose to organs at risk in patients with cervical cancer.
    Christensen EN; Yu HZ; Klopp AH; Tsai JC; Lawyer AA; Court LE; Eifel PJ
    Brachytherapy; 2014; 13(3):240-9. PubMed ID: 24188993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
    Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
    Kim RY; Shen S; Duan J
    Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer.
    Vinod SK; Caldwell K; Lau A; Fowler AR
    J Med Imaging Radiat Oncol; 2011 Jun; 55(3):304-10. PubMed ID: 21696566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
    Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
    Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
    Simha V; Rai B; Patel FD; Kapoor R; Sharma SC; Singh OA; Singla V; Dhanireddy B; Ghoshal S
    Brachytherapy; 2018; 17(2):345-351. PubMed ID: 29102740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
    Ohkubo Y; Ohno T; Noda SE; Kubo N; Nakagawa A; Kawahara M; Abe T; Kiyohara H; Wakatsuki M; Nakano T
    J Radiat Res; 2013 Nov; 54(6):1138-45. PubMed ID: 23732770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of applicators orientations on bladder, and rectal doses in gynecological mHDR brachytherapy: A retrospective analysis of reproducibility in multi-fractionated regimen.
    Srivastava AK; Rastogi M; Mishra SP
    J Cancer Res Ther; 2019; 15(6):1345-1351. PubMed ID: 31898671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer.
    Liu H; Kinard J; Maurer J; Shang Q; Vanderstraeten C; Hayes L; Sintay B; Wiant D
    J Appl Clin Med Phys; 2018 Nov; 19(6):316-322. PubMed ID: 30284370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
    Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
    Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
    J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer?
    Kim HJ; Kim S; Ha SW; Wu HG
    Tumori; 2008; 94(3):327-32. PubMed ID: 18705399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
    Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should the organs at risk be contoured in vaginal cuff brachytherapy?
    Holloway CL; Macklin EA; Cormack RA; Viswanathan AN
    Brachytherapy; 2011; 10(4):313-7. PubMed ID: 21193355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.